Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 4 | Allergy, Asthma & Clinical Immunology

Fig. 4

From: Anti-asthmatic miR-224-5p inhibits the FHL1/MAPK pathway to repress airway smooth muscle cell proliferation in a murine model of asthma-like airway inflammation

Fig. 4

Knockdown of FHL1 induces inhibition of ASMC proliferation and promotion of their apoptosis in vitro. ASMCs isolated from normal mice remained non-transduced while ASMCs from asthmatic mice were transduced with oe-FHL1/oe-NC or sh-FHL1/sh-NC. A ASMCs from asthmatic mice identified by immunofluorescence. Morphological characteristics (a) and fluorescence microscopic observation (b) of ASMCs. B FHL1 mRNA expression in ASMCs determined by RT-qPCR. C, ASMC viability assessed by MTT assay. D Protein levels of cleaved PARP and cleaved caspase-3 in ASMCs measured by Western blot analysis. E Flow cytometric data showing cell cycle distribution. F Flow cytometric data showing apoptosis of ASMCs. * p < 0.05 compared with ASMCs from normal mice. # p < 0.05 compared with asthmatic mice-derived ASMCs transfected with sh-NC. $ p < 0.05 compared with asthmatic mice-derived ASMCs transfected with oe-NC. Cell experiments were performed in triplicate

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us